Life Tech, CollabRx Ink Deal to Elucidate MDx Information | GenomeWeb

NEW YORK (GenomeWeb News) – CollabRx announced after the close of the market Wednesday a development and commercialization partnership pairing its technology and content resources with Life Technologies' cancer diagnostics development and laboratory-developed test services business.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.